funiculosin (anthraquinone) has been researched along with Leukemia P388 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crooke, ST; Faucette, LF; Johnson, RK; McCabe, FL; Mirabelli, CK; Sung, CM | 1 |
1 other study(ies) available for funiculosin (anthraquinone) and Leukemia P388
| Article | Year |
|---|---|
A murine model to evaluate the ability of in vitro clonogenic assays to predict the response to tumors in vivo.
Topics: Animals; Anthracyclines; Anthraquinones; Carboplatin; Cisplatin; Colony-Forming Units Assay; Daunorubicin; Doxorubicin; Humans; Leukemia P388; Mice; Naphthacenes; Organoplatinum Compounds; Tumor Stem Cell Assay | 1988 |